Jia Yueting: Investment in Qualigen Therapeutics is expected to be completed this week
Foresight News reported that Jia Yueting, founder of the smart electric vehicle company Faraday Future, tweeted that Faraday Future's $30 million investment in Qualigen Therapeutics (QLGN) has more than doubled its market value. The strategic investment is expected to be completed next week (this week in East 8th time zone).
According to previous Foresight News reports, Faraday Future announced a PIPE investment of approximately $41 million to acquire shares in Qualigen Therapeutics, and plans to jointly develop crypto and Web3 businesses. After the transaction is completed, QLGN will be renamed CXC10 and will fully focus on the crypto and Web3 ecosystem. Faraday Future and its founder Jia Yueting are expected to hold a combined stake of over 62%, with Jia Yueting personally investing $4 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Data: 617.77 BTC transferred from an anonymous address and, after intermediary steps, flowed into an exchange.
Today, 10 US Bitcoin ETFs saw a net outflow of 349 BTC, while 9 Ethereum ETFs recorded a net inflow of 36,459 ETH.
Trending news
MoreData: In the past 24 hours, total liquidations across the network reached $257 millions, with long positions liquidated for $82.7567 millions and short positions liquidated for $174 millions.
Fidelity International optimistic about emerging market assets next year, says large-scale capital has yet to enter
Crypto prices
More
